Assessment report for Cyramza (ramucirumab), 17 December 2015, EMA/CHMP/69143/2016.
"No ERA was submitted."
Fass environmental information for Cyramza from Lilly (downloaded 2019-09-04).
According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CHMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids proteins, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment.
Author: Health and Medical Care Administration, Region Stockholm